KPTI
Karyopharm Therapeutics Inc
NASDAQ: KPTI · HEALTHCARE · BIOTECHNOLOGY
$8.31
-1.07% today
Updated 2026-04-30
Market cap
$195.22M
P/E ratio
—
P/S ratio
1.34x
EPS (TTM)
$-17.80
Dividend yield
—
52W range
$4 – $11
Volume
1.0M
Karyopharm Therapeutics Inc (KPTI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-8.55M | $-15.51M | $-30.29M | $-51.45M | $-94.03M | $-84.39M | $-73.72M | $-159.12M | $-190.82M | $-160.23M | $-107.12M | $-149.55M | $-92.72M | $-127.49M | $-75.37M |
| Capital expenditures | $376000.00 | $121000.00 | $57000.00 | $2.83M | $1.42M | $70000.00 | $62000.00 | $2.36M | $206000.00 | $145000.00 | $5.71M | $118000.00 | $0.00 | $142000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $24000.00 | $653000.00 | $3.79M | $14.24M | $17.06M | $22.28M | $20.41M | $17.27M | $15.29M | $24.41M | $29.78M | $35.40M | $21.71M | $18.43M | $14.05M |
| Free cash flow | $-8.93M | $-15.63M | $-30.35M | $-54.28M | $-95.44M | $-84.46M | $-73.78M | $-161.48M | $-191.03M | $-160.38M | $-112.83M | $-149.67M | $-92.72M | $-127.63M | $-75.37M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $155.58M | $-5.37M | $-92.25M | $-8.70M | $19.33M | $49.33M | $11.93M | $-41.84M | $108.37M | $-60.07M | — | — | — |